[引用][C] Time‐dependent kinetics VI: Direct relationship between equations for drug levels during induction and those involving constant clearance

RH Levy, MS Dumain - Journal of Pharmaceutical Sciences, 1979 - Wiley Online Library
In a previous report (l), equations were derived to describe the time course of drug levels
during enzyme induction under various drug input conditions: single-dose intravenous …

[引用][C] Pharmacokinetics—Master or servant?

CT Dollery - European Journal of Clinical Pharmacology, 1973 - Springer
Clinical pharmacology is accepted as an academic discipline in the United Staates, Sweden
and the United Kingdom, and it is developing in a number of other countries. There is …

Enalapril maleate (MK-421), a potent, nonsulfhydryl angiotensin-converting enzyme inhibitor: absorption, disposition, and metabolism in man

EH Ulm - Drug metabolism reviews, 1983 - Taylor & Francis
This paper must necessarily take the form of a progress report. Many aspects of our work,
particularly with regard to human disposition and metabolism, are continuing at this time …

Definition and implications of dose-dependent kinetics in clinical medicine

JL Holtzman - Drug Metabolism Reviews, 1983 - Taylor & Francis
Definition and Implications of Dose-Dependent Kinetics in Clinical Medicine Page 1 DRUG
METABOLISM REVIEWS, 14( 61, 1103-1117 (1983) Definition and Implications of DoseDependent …

[PDF][PDF] Converting-enzyme inhibition experiences with captopril in hypertensive patients

EJL Prins - 1979 - research.rug.nl
Evidence of effectiveness of a newly developed drug is obtained from an organized search
for an expected result in a selected population. In contrast, the search for risks is open …

Cimetidine does not alter free unchanged captopril pharmacokinetics and biological effects in healthy volunteer.

C Richer, M Bah, M Cadilhac, C Thuillez… - Journal de …, 1986 - europepmc.org
The effects of cimetidine (single or repeated administration) on free unchanged captopril
plasma levels, pharmacokinetic parameters and plasma converting enzyme inhibitory effects …

Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension.

BC Campbell, AN Shepherd… - British Journal of Clinical …, 1982 - Wiley Online Library
1 The effects of the orally active angiotensin converting enzyme inhibitor, captopril, were
examined in 15 patients with mild or moderate essential hypertension. 2 Following initial …

Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients.

C Richer, B Giroux, PF Plouin, B Maarek… - British journal of …, 1984 - Wiley Online Library
The kinetics of captopril plasma levels and of the drug‐induced plasma converting enzyme
activity (PCEA), plasma renin activity (PRA) and diastolic blood pressure (DBP) …

Chronic treatment of hypertensive patients with converting enzyme inhibitors

J Nussberger, J Biollaz, B Waeber… - Journal of …, 1986 - journals.lww.com
It is widely accepted that pharmacologic reduction of the blood pressure of hypertensive
patients reduces the risk of at least some of the major cardiovascular complications (1–5). All …

Kinetics of drug metabolism inhibition: use of metabolite concentration-time profiles

PN Shaw, JB Houston - Journal of pharmacokinetics and …, 1987 - Springer
A simple model simulating the kinetics of drug metabolism inhibition interaction is
investigated. The relative sensitivity of drug and metabolite concentration-time profiles as …